Vicor Technologies is a development-stage biotechnology company that focuses on the commercialization of noninvasive diagnostic technologies. It offers PD2i Cardiac Analyzer, which is a medical device based on a patented, proprietary algorithm that evaluates electrophysiological potentials to predict future pathological events. The company has also developed PD2i Vital Sign, which is a device that assesses the severity of injury and probability of survival for critically injured combat casualties and ill civilian patients. Vicor Technologies products are used by more than 12 million patients throughout the world. In addition, the company is involved in the preclinical and early clinical development of specific naturally occurring peptides and proteins that treat a range of human diseases. It works in association with the U.S. Army Institute for Surgical Research, Target Health and Harvard Clinical Research Institute.
Partial Data by Infogroup (c) 2024. All rights reserved.